Skip to main content

Global CTL019

Global CTL019

Contact

If you are interested in participating in the study or want to learn more, please get in touch. Contact us
This study is no longer recruiting.

Description

The purpose of this study is to evaluate the efficacy of Cart 19 cells therapy as measured by overall remission rate, which includes Complete Remission and Complete Remission with incomplete blood count recovery assessment in infants to adults. This study involves administer of the study drug, chemotherapy, and blood draws Reimbursement for travel may be provided. If you have questions or would like to learn more about the study, please contact the Principal Investigator, Dr. Grupp at (215) 590-5475.

Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.

Jump back to top